Capital expenditure increased 55.6%
Capital expenditure changed +55.6% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed +55.6% from the comparable as-filed period.
Cash / debt changed +8380 basis points from the comparable as-filed period.
Debt / assets changed -377 basis points from the comparable as-filed period.
Receivables / revenue changed +326 basis points from the comparable as-filed period.
Gross profit changed +16.6% from the comparable as-filed period.
SBC / revenue changed -184 basis points from the comparable as-filed period.
Debt / revenue changed -1961 basis points from the comparable as-filed period.
Working capital / assets changed +254 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Research & development changed +12.3% from the comparable as-filed period.
Gross margin changed +42 basis points from the comparable as-filed period.
Net debt changed -421.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Operating cash-flow margin changed +201 basis points from the comparable as-filed period.
Working capital changed +11.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Free-cash-flow margin changed +184 basis points from the comparable as-filed period.
Current ratio changed +12.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Capex / revenue changed +17 basis points from the comparable as-filed period.
R&D / revenue changed -75 basis points from the comparable as-filed period.
Stock-based compensation changed -3.7% from the comparable as-filed period.
Gross debt changed +0.0% from the comparable as-filed period. The change ranks at the 38th percentile of 8 prior comparable changes.
Reported total debt changed +0.0% from the comparable as-filed period. The change ranks at the 38th percentile of 8 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.